Glutamic Acid Market Report 2025

This Glutamic Acid market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The glutamic acid market size has grown strongly in recent years. It will grow from $12.29 billion in 2024 to $13.42 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to food and beverage industry, pharmaceutical and healthcare sector, industrial applications, population growth, increased consumption of processed food.

The glutamic acid market size is expected to see rapid growth in the next few years. It will grow to $19.96 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to expanding pharmaceutical market, sustainability and biodegradable plastics, clean label food products, ongoing research and development, biofuels and green chemistry. Major trends in the forecast period include plant-based glutamic acid, health and wellness supplements, advanced fermentation technologies, expansion of flavor enhancers, personalized nutrition.

The anticipated growth in the glutamic acid market is driven by the rising demand for the food service industry. The food service industry, involving the preparation, distribution, and sale of food and beverages outside consumers' homes, plays a pivotal role in the increased usage of glutamic acid. Glutamic acid, often in the form of monosodium glutamate (MSG), is a widely utilized flavor enhancer in processed and convenience foods, meat and seafood products, and international cuisines. As the food service industry continues to cater to consumers seeking diverse, flavorful, and convenient food options, the demand for glutamic acid is expected to grow. The cost-effectiveness of glutamic acid in enhancing flavor aligns with consumer preferences and supports food innovation and product development. For instance, a report published by the United States Department of Agriculture in July 2023 indicates a steady increase in global food provided by the food service and retail sectors, reaching $2.39 trillion in 2022, compared to $2.11 trillion in 2021. The corresponding figures for global food service establishments were $1.34 trillion in 2022 and $1.16 trillion in 2021, reflecting the industry's expansion and driving the growth of the glutamic acid market.

The growth of the pharmaceutical industry is anticipated to boost the demand for glutamic acid in the future. Glutamic acid is utilized in medicines, supplements, and research, aligning with current health and wellness trends. As pharmaceutical companies invest in research and development to tackle various health issues and serve an aging population, the need for glutamic acid continues to rise. For example, a report published by the Office for National Statistics, a UK government department, revealed that between 2020 and 2021, healthcare spending in the UK grew by 9.4% in nominal terms and 9.7% in real terms. The total healthcare expenditure in the UK for 2021 reached $367.25 billion (£280.7 billion), with pharmaceutical spending at $51.84 billion (£3.96 billion) in that year. Consequently, the expansion of the pharmaceutical industry is driving the growth of the glutamic acid market.

A notable trend in the glutamic acid market is the emergence of strategic collaborations and partnerships among major companies. These collaborations aim to enhance business sustainability and leverage complementary expertise. For example, in March 2023, Corteva, Inc., a US-based agricultural chemical company, and Bunge Limited, a US-based food company, announced a collaboration focused on developing more nutritious soybean meal for the animal feed industry. This partnership combines Corteva's expertise in germplasm, gene editing, and trait discovery with Bunge's capabilities in processing and merchandising. The goal is to create soybean varieties with increased protein content, optimized amino acid profiles, and reduced levels of anti-nutritional factors. This collaboration aims to reduce the use of synthetic additives in animal feed, lower costs, and decrease carbon emissions, demonstrating a trend of strategic partnerships shaping the future of the glutamic acid market.

Major companies in the glutamic acid market are strategically developing new products to gain a competitive advantage. One notable example is METEX NØØVISTAGO, a biotechnology company based in France, which launched the animal nutrition solution inneus in May 2022. inneus is designed for piglets and poultry, combining functional amino acids with selected polyphenols to enhance intestinal health. This innovative product aims to help animals better cope with various physiological and health challenges, including weaning for piglets and coccidiosis for chickens. inneus offers a unique approach to improving digestive health in monogastric animals and has garnered support through scientific publications presented in relevant congresses. This strategic development aligns with the growing focus on animal health and nutrition in the agricultural sector.

In November 2023, Grand Pharma, a pharmaceutical company based in China, acquired 100% equity of Hubei Bafeng Company. This acquisition positions Grand Pharma as the pharmaceutical company with the highest number of registration numbers for amino acid Active Pharmaceutical Ingredients (APIs) in China, thereby expanding its portfolio. Hubei Bafeng is a manufacturer of glutamic acid located in China.

Major companies operating in the glutamic acid market include AMINO GmbH, Evonik Industries AG, Fufeng Group, Hefei TNJ Chemical Industry Co Ltd., Kyowa Hakko Bio Co Ltd., Medinex Laboratories Pvt Ltd., Sichuan Tongsheng Amino acid Co Ltd, Wuhan Amino Acid Bio-Chemical Co Ltd., Global Bio-chem Technology Group Company Limited, Ningxia Yipin Biological Technology Co Ltd., Akzo Nobel N.V., Iris Biotech GmbH, Luojiang Chenming Biological Products Co Ltd., Ajinomoto Co Inc., Haihang Industry Co Ltd., Avenit AG, Suzhou Yuanfang Chemical Co Ltd., CJ CheilJedang Corp, Meihua Holdings Group Co Ltd., Ningxia Eppen Biotech Co Ltd., Shandong Linghua Monosodium Glutamate Incorporated Company, COFCO Biochemical, Cargill Incorporated, Ambuja Group, Roquette Frères.

North America was the largest region in the glutamic acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glutamic acid market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the glutamic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Glutamic acid is utilized to construct proteins, contributing to improved memory and focus, immune system support, prostate health, detoxification, enhanced athletic performance, and aid in digestion. Glutamic acid is a form of amino acid that converts to glutamate, a chemical crucial for communication between nerve cells in the brain, facilitating the transmission of information. It plays a vital role in protein synthesis and is integral to the central nervous system, participating in various bodily processes that contribute to its diverse benefits.

The main types of glutamic acid include biosynthesis and industrial synthesis. Products from industrial organic synthesis serve as intermediates in various chemical processes. Glutamic acid can be derived from plant-based or animal-based sources, finding applications in pharmaceuticals, food additives, animal and pet food, and various other applications.

The glutamic acid market research report is one of a series of new reports that provides glutamic acid market statistics, including global market size, regional shares, competitors with a glutamic acid market share, detailed glutamic acid market segments, market trends and opportunities, and any further data you may need to thrive in the glutamic acid industry. This glutamic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glutamic acid market consists of sales of glutamic acid that is used in the body to build proteins. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.